iBio, Inc. financial data

Symbol
IBIO on Nasdaq
Location
600 Madison Avenue, Suite 1601, New York, NY
Fiscal year end
June 30
Latest financial report
10-K - Q2 2025 - Sep 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 182 % +29.8%
Quick Ratio 0 %
Debt-to-equity 52.8 % -55.8%
Return On Equity -127 % +12.6%
Return On Assets -83.1 % -25.5%
Operating Margin -53.6K % -2906%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19.7M shares +128%
Common Stock, Shares, Outstanding 19.3M shares +124%
Entity Public Float 22.4M USD +406%
Common Stock, Value, Issued 19K USD +111%
Weighted Average Number of Shares Outstanding, Basic 10.5M shares +174%
Weighted Average Number of Shares Outstanding, Diluted 10.5M shares +174%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 50K USD -97.2%
Revenue from Contract with Customer, Excluding Assessed Tax 400K USD
Research and Development Expense 8.31M USD +60.3%
General and Administrative Expense 10.7M USD -8.43%
Operating Income (Loss) -18.6M USD -11.8%
Nonoperating Income (Expense) 225K USD -81.1%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -18.4M USD +26.2%
Earnings Per Share, Basic -1 USD/shares +73.1%
Earnings Per Share, Diluted -1 USD/shares +73.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.58M USD -39.6%
Cash, Cash Equivalents, and Short-term Investments 6.43M USD -34.5%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Inventory, Net 0 USD
Assets, Current 9.72M USD -38%
Property, Plant and Equipment, Net 3.16M USD -12.9%
Operating Lease, Right-of-Use Asset 2.05M USD -14.6%
Intangible Assets, Net (Excluding Goodwill) 6.85M USD +27.6%
Assets 23.2M USD -19.3%
Accounts Payable, Current 2.19M USD +511%
Employee-related Liabilities, Current 876K USD -44.1%
Accrued Liabilities, Current 1.35M USD -33.7%
Contract with Customer, Liability, Current 1.2M USD +500%
Liabilities, Current 6.11M USD +59%
Operating Lease, Liability, Noncurrent 2.2M USD -18.2%
Liabilities 8.31M USD +12.1%
Retained Earnings (Accumulated Deficit) -332M USD -5.86%
Stockholders' Equity Attributable to Parent 14.9M USD -30.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 14.9M USD -30.2%
Liabilities and Equity 23.2M USD -19.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.72M USD +30.4%
Net Cash Provided by (Used in) Financing Activities -162K USD -107%
Net Cash Provided by (Used in) Investing Activities 713K USD +1326%
Common Stock, Shares Authorized 275M shares 0%
Common Stock, Shares, Issued 19.3M shares +124%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.16M USD -12.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.79M USD -39.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 57K USD -71.5%
Deferred Tax Assets, Valuation Allowance 63.4M USD +15.6%
Depreciation 120K USD -27.3%
Lessee, Operating Lease, Liability, to be Paid 3.17M USD -16.9%
Property, Plant and Equipment, Gross 4.66M USD +0.32%
Operating Lease, Liability, Current 490K USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 688K USD +2.84%
Lessee, Operating Lease, Liability, to be Paid, Year One 669K USD +3.24%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 709K USD +3.05%
Deferred Tax Assets, Operating Loss Carryforwards 56.1M USD +14.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 731K USD +3.1%
Operating Lease, Payments 563K USD 0%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 20K USD 0%
Share-based Payment Arrangement, Expense 1.53M USD -22.5%
Interest Expense 52K USD +48.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%